Aug 25, 2022 / 07:00AM GMT
Nicolai Thomsen - Ambu A/S-Director of IR&Strategic Financial Planning
Good morning, everyone, and welcome to the conference call for Ambu's Q3 Results. I'm Nicolai Thomsen from the Investor Relations team. I'm here with our CEO, Britt Meelby Jensen; and our CFO, Thomas Frederik Schmidt.
Today's presentation can be found on our home page and there will be a Q&A session at the end of the call. And with that brief introduction, I'm very happy to hand over the word to our CEO, Britt Meelby Jensen.
Britt Meelby Jensen - Ambu A/S-CEO&Member of Management Board
Good morning, everyone. Hope you're well. Nice to have you on the call for this Q3 results. For those of you who may not know me, I've spent over 20 years in health care, in senior leadership positions at Novo Nordisk as CEO of DARCO, Zealand Pharma and most recently as CEO of Ates Medical. Also, I've been on the Board of Directors of Ambu for almost 3 years.
Thomas Schmidt
Q3 2022 Ambu A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
